Related Experiment Video
Updated: Jan 13, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Interventions for prediabetes: an umbrella review of systematic reviews and meta-analyses of randomized controlled
Nicola Veronese1, Stefania Maggi2, Cristina Giussani3
1Saint Camillus International University of Health Sciences, Faculty of Medicine, Rome, Italy.
Aims:
This umbrella review synthesized evidence from systematic reviews and meta-analyses of randomized controlled trials (RCTs) to assess the effectiveness of interventions for preventing adverse outcomes in individuals with prediabetes.
Methods:
A total of 23 meta-analyses comprising 602 RCTs and over 30,000 participants were analyzed from databases including Medline, Embase, Web of Science, and Cochrane through February 1, 2025. Interventions evaluated included both pharmacological and non-pharmacological strategies compared to placebo or usual care. Studies reporting only bio-humoral markers were excluded. The GRADE approach was used to assess the certainty of evidence.
Results:
Among 15 evaluated interventions, four were supported by high-certainty evidence for diabetes prevention: GLP-1 receptor agonists (RR = 0.26), liraglutide/exenatide/semaglutide (OR = 0.29), orlistat (OR = 0.67), and structured self-care programs (OR = 0.58). High-certainty evidence also supported modest reductions in systolic blood pressure (∼2-3 mmHg) from lifestyle interventions, digital health tools, and liraglutide. Significant reductions in BMI and waist circumference were observed with pharmacologic agents, aerobic exercise, and digital platforms. However, metformin combined with lifestyle changes did not yield notable anthropometric benefits.
Conclusion:
These findings underscore the value of a multidimensional and personalized approach to prediabetes management, emphasizing evidence-based pharmacological options alongside behavioral and digital health strategies.
Systematic Review Registration:
PROSPERO CRD42025649619.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

